ID: ALA3120243

Max Phase: Preclinical

Molecular Formula: C16H21N3O

Molecular Weight: 271.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1c2ccccc2ncn1CCCN1CCCCC1

Standard InChI:  InChI=1S/C16H21N3O/c20-16-14-7-2-3-8-15(14)17-13-19(16)12-6-11-18-9-4-1-5-10-18/h2-3,7-8,13H,1,4-6,9-12H2

Standard InChI Key:  WUQNHSICRZGUAS-UHFFFAOYSA-N

Associated Targets(non-human)

Trachea 249 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 271.36Molecular Weight (Monoisotopic): 271.1685AlogP: 2.27#Rotatable Bonds: 4
Polar Surface Area: 38.13Molecular Species: BASEHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.98CX LogP: 1.88CX LogD: 0.29
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.86Np Likeness Score: -1.51

References

1. Špulák M, Pourová J, Vopršálová M, Mikušek J, Kuneš J, Vacek J, Ghavre M, Gathergood N, Pour M..  (2014)  Novel bronchodilatory quinazolines and quinoxalines: synthesis and biological evaluation.,  74  [PMID:24445313] [10.1016/j.ejmech.2013.12.024]

Source